183 related articles for article (PubMed ID: 31918259)
1. Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
Escoll M; Lastra D; Pajares M; Robledinos-Antón N; Rojo AI; Fernández-Ginés R; Mendiola M; Martínez-Marín V; Esteban I; López-Larrubia P; Gargini R; Cuadrado A
Redox Biol; 2020 Feb; 30():101425. PubMed ID: 31918259
[TBL] [Abstract][Full Text] [Related]
2. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
3. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D
Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672
[TBL] [Abstract][Full Text] [Related]
5. ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells.
Cong ZX; Wang HD; Wang JW; Zhou Y; Pan H; Zhang DD; Zhu L
Oncol Rep; 2013 Aug; 30(2):715-22. PubMed ID: 23708697
[TBL] [Abstract][Full Text] [Related]
6. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
7. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model.
Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD
Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813
[TBL] [Abstract][Full Text] [Related]
9. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
10. Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription.
Nawaz Z; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Sci Rep; 2016 Jun; 6():27753. PubMed ID: 27291091
[TBL] [Abstract][Full Text] [Related]
11. Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program.
Wei Y; Luo H; Yee PP; Zhang L; Liu Z; Zheng H; Zhang L; Anderson B; Tang M; Huang S; Li W
Adv Sci (Weinh); 2021 Dec; 8(24):e2102653. PubMed ID: 34716691
[TBL] [Abstract][Full Text] [Related]
12. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation.
Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS
Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791
[TBL] [Abstract][Full Text] [Related]
13. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
14. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation.
Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y
Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981
[TBL] [Abstract][Full Text] [Related]
15. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
16. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.
Yuan J; Xiao G; Peng G; Liu D; Wang Z; Liao Y; Liu Q; Wu M; Yuan X
Biochem Biophys Res Commun; 2015 Feb; 457(2):171-6. PubMed ID: 25542152
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
19. Hippo Signaling Pathway in Gliomas.
Masliantsev K; Karayan-Tapon L; Guichet PO
Cells; 2021 Jan; 10(1):. PubMed ID: 33477668
[TBL] [Abstract][Full Text] [Related]
20. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
